X
Hikma rises on cancer generic deal with China’s Hansoh
https://pharmaphorum.com/news/hikma-rises-on-cancer-generic-deal-with-chinas-hansoh/
Hikma
Hikma in dispute with FDA over Advair generic
Hikma to give up date in Q1 next year.
GSK gets short term boost as second US Advair generic rejected
FDA rejects Hikma drug, regulator has “major” issue with Mylan’s rival.
Vectura and Hikma to develop US asthma generic
Firms extend existing respiratory deal.
Hikma’s new generics business has slow start
Profits hit as drug approvals delayed.